Relmada Therapeutics Inc. (RLMD)
NASDAQ: RLMD
· Real-Time Price · USD
0.59
-0.03 (-5.01%)
At close: Aug 20, 2025, 11:28 AM
Relmada Therapeutics Revenue
Relmada Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Relmada Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
17
Market Cap
19.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Jun 30, 2019 | 0 | n/a |
| Jun 30, 2018 | 0 | n/a |
| Jun 30, 2017 | 0 | n/a |
| Jun 30, 2016 | 0 | n/a |
| Jun 30, 2015 | 0 | -100.00% |
| Aug 31, 2013 | 5.13K | -35.41% |
| Aug 31, 2012 | 7.94K | n/a |